Abstract
We are following 60 patients with morphea and/or linear scleroderma at the Hospital for Sick Children, Toronto. Lesions may vary in depth from epidermal changes resembling lichen sclerosis, to superficial and deep dermal changes. The subcutaneous tissue, bone and muscle may be involved. There is no good clinical marker of the disease. Because of the variation in the time to cure, it is difficult to evaluate treatment regimens. We are currently using methotrexate weekly either orally or subcutaneously and monthly pulsed steroids for three months.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
De Silva U, Parish LC: Historical approach to scleroderma. Clinics in Dermatol. 12: 201–205. 1994.
Peterson LS, Nelson AM, Daniel WP: Subspecialty clinics: Rheumatology and dermatology. Classification of morphea (localized scleroderma). Mayo Clin Proc. 70: 1068–1076. 1995.
Jablonska S: Scleroderma and pseudoscleroderma. 2nd Ed. Warsaw Poland: Polish Medical Publishers, pgs 537–546. 1975.
Buechner SA, Winkelmann RK, Lautenschlager S, Gilli L, Rufli T: Localized scleroderma associated with Borrelia burgdorferi infection. J Am Acad Dermatol. 29: 190–196. 1993.
Birdi M, Shore A, Rush P, et al: Childhood linear slceroderma — A possible role of thermography for evaluation. J Rheumatol. 19: 968–973. 1992.
Meis JF, Koopman R, van Bergen B, Pool G, Melchers W: No evidence for a relation between Borrelia burgdorferi infection and old lesions of localized scleroderma (morphea). Letter to Editor. Arch Dermatol. 129: 386–387. 1993.
Rosenberg AM, Uziel Y, Krafchik BR, et al: Antinuclear antibodies in children with localized scleroderma. J Rheumatol. 22: 2337–2343. 1995.
Sato S, Ihn H, Soma Y, et al: Antihistone antibodies in patients with localized scleroderma. Arthritis Rheum. 36: 1137–1141. 1993.
Takehara K, Moroi Y, Nakabayashi Y, Ishibashi Y: Antinuclear antibodies in localized scleroderma. Arthritis Rheum. 26: 612–616. 1983.
Birdi N, Laxer RM, Thorner P, Fritzler MJ, Silverman ED: Localized scleroderma progressing to systemic disease. Case report and review of the literature. Arthritis Rheum. 36(3): 410–415. 1993.
Uziel Y, Krafchik BR, Feldman B, Silverman ED, Rubin LA, Laxer RM: Serum levels of soluble inter-leukin-2 receptor. A marker of disease activity in localized scleroderma. Arthritis Rheum. 37(6): 898–901. 1994.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Krafchik, B.R. (1999). Localized Morphea in Children. In: Mallia, C., Uitto, J. (eds) Rheumaderm. Advances in Experimental Medicine and Biology, vol 455. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4857-7_7
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4857-7_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7203-5
Online ISBN: 978-1-4615-4857-7
eBook Packages: Springer Book Archive